Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

Tolerance Bio signs $560m worldwide TLB-33 deal with Tanabe Pharma

Sep 29, 2026, 8:57 AM

Read Full Article → Tolerance Bio signs $560m worldwide TLB-33 deal with Tanabe Pharma

Tolerance Bio signs $560m worldwide TLB-33 deal with Tanabe Pharma

Translate article text

Choose a language and wait for the translated text.

Tolerance Bio has signed an agreement securing an exclusive licence from Tanabe Pharma for TLB-33 in a deal of up to around $560m.

Tolerance Bio signs $560m worldwide TLB-33 deal with Tanabe Pharma | PharmaVoice